Policy expert Paul Melmeyer breaks down what the current NIH funding decisions (in late Jan 2026) could mean for research momentum and patients.
All tagged muscular dystrophy
Policy expert Paul Melmeyer breaks down what the current NIH funding decisions (in late Jan 2026) could mean for research momentum and patients.
World-renowned geneticist, Madhuri Hegde, and Genetic counselor, Ann Martin discuss the genetics of Duchenne Muscular Dystrophy (DMD) and potential treatments.
The fascinating genetics of FSHD is discussed including diagnosis through whole genome optical mapping.